SCHEMBL5092707

SCHEMBL5092707

CCCCCC#C/C=C\C#Cc1ccccc1C#N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.38
TSHR P16473 3/20 0.38
KCNH2 Q12809 1/20 0.38
MAPT P10636 4/20 0.37
KDM4E B2RXH2 3/20 0.37
HSD17B10 Q99714 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
ALOX12 P18054 1/20 0.37
CYSLTR2 Q9NS75 1/20 0.35
CYSLTR1 Q9Y271 1/20 0.35
HMGCR P04035 2/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
CYP2C9 P11712 3/20 0.33
CYP2C19 P33261 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GRM2 Q14416 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5092715 1.00 CYP3A4 (0.38) CYP3A4TSHRKCNH2MAPTKDM4E
SCHEMBL5100842 0.95 TSHR (0.38) CYP3A4TSHRKCNH2MAPTKDM4E
SCHEMBL5100838 0.95 TSHR (0.38) CYP3A4TSHRKCNH2MAPTKDM4E
SCHEMBL28622511 0.84 KCNH2 (0.47) CYP3A4TSHRKCNH2MAPTKDM4E
SCHEMBL5092518 0.83 KCNH2 (0.46) CYP3A4TSHRKCNH2MAPTKDM4E
SCHEMBL5092719 0.79 TSHR (0.46) TSHRKCNH2KDM4EHSD17B10ALDH1A1
SCHEMBL5092713 0.79 TSHR (0.46) TSHRKCNH2KDM4EHSD17B10ALDH1A1
SCHEMBL5089552 0.78 CYP3A4 (0.40) CYP3A4TSHRKCNH2MAPTKDM4E
SCHEMBL5089556 0.78 CYP3A4 (0.40) CYP3A4TSHRKCNH2MAPTKDM4E
SCHEMBL5100674 0.78 CYP3A4 (0.46) CYP3A4TSHRKCNH2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332623-B2 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2008-02-19 US disclosed
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds CCNI, TOP1, TOP2B CYP3A4 542/4885TSHR 1305/4885KCNH2 1925/4885
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds CCNI, TOP2B, TOP2A CYP3A4 1065/4885TSHR 730/4885KCNH2 619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.